Role of plasma cells in Waldenström macroglobulinaemia
- 6 May 2017
- journal article
- research article
- Published by Elsevier BV in Pathology
- Vol. 49 (4), 337-345
- https://doi.org/10.1016/j.pathol.2017.02.004
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalitiesLaboratory Investigation, 2012
- Temporal and geographic variations of Waldenstrom macroglobulinemia incidenceCancer, 2011
- Immunophenotyping in multiple myeloma and related plasma cell disordersBest Practice & Research Clinical Haematology, 2010
- Chemokines and chemokine receptors: new insights into cancer-related inflammationTrends in Molecular Medicine, 2010
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphomaNature, 2010
- Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphomaNature, 2009
- TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphomaThe Journal of Experimental Medicine, 2009
- Igβ tyrosine residues contribute to the control of B cell receptor signaling by regulating receptor internalizationThe Journal of Experimental Medicine, 2006
- Toll-like receptor signallingNature Reviews Immunology, 2004
- Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003